AbbVie Inc.·4

Mar 3, 6:10 PM ET

Donoghoe Nicholas 4

4 · AbbVie Inc. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

AbbVie EVP Nicholas Donoghoe Sells 12,874 Shares for Tax Withholding

What Happened

  • Nicholas Donoghoe, Executive Vice President & Chief Business/Strategy Officer at AbbVie (ABBV), had 12,874 shares disposed on Feb 27, 2026 at $232.08 per share for a total of $2,987,798. The Form 4 lists the transaction code "F," indicating the shares were surrendered to satisfy tax withholding related to an equity award or option event (a disposition rather than a voluntary open-market sale).

Key Details

  • Transaction date: 2026-02-27
  • Price per share: $232.08; Shares disposed: 12,874; Gross value: $2,987,798
  • Transaction code: F (payment of exercise price or tax liability — typically shares withheld to cover taxes)
  • Filing date / accession: Form 4 filed 2026-03-03 (filed within the SEC’s two-business-day deadline)
  • Shares owned after transaction: not specified in the provided summary filing

Context

  • This was a tax-withholding disposition (common after option exercises or vesting). Such withholdings are routine administrative actions to cover tax obligations and are not the same as a discretionary open-market sale that might signal an insider view of the stock. The filing appears timely under SEC Form 4 rules.

Insider Transaction Report

Form 4
Period: 2026-02-27
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2026-02-27$232.08/sh12,874$2,987,79874,430 total
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Nicholas J. Donoghoe|2026-03-03

Documents

1 file
  • 4
    form4-03032026_060301.xmlPrimary